BANK OF AMERICA CORP /DE/
BankPosition in RYTM — Rhythm Pharmaceuticals, Inc.
CIK 70858
CHARLOTTE, NC
Position in RYTM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$36,136,932
-$18,538,234 QoQ
Shares Held
325,470
-48.2% QoQ
Ownership
0.473%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 87%
Shared 0%
None 13%
Common Shares in RYTM Over Time
Shares Held
Position Value (USD)
Derivatives in RYTM
reported options exposure · as of Dec 31, 2024CallValue
$363,870
CallShares
6,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. RYTM ranks #62 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in RYTM
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $36,136,932 | 325,470 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $54,675,166 | 628,667 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $24,028,763 | 224,484 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $23,545,814 | 233,150 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $14,037,782 | 222,152 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,919,501 | 111,752 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $363,870 | 6,500 | Call | Defined | 2025-02-14 | |
| 2024-12-31 | $5,849,236 | 104,488 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $539,617 | 10,300 | Call | Defined | 2024-11-14 | |
| 2024-09-30 | $5,566,434 | 106,250 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,779,283 | 92,043 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,814,568 | 111,114 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,211,921 | 69,870 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,527,318 | 110,243 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,310,544 | 140,118 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,416,439 | 359,666 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $7,750,375 | 266,153 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $5,351,020 | 218,409 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $203,812 | 49,112 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $456,362 | 39,615 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,223,894 | 122,635 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $2,670,284 | 204,463 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,343,293 | 119,678 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $2,264,019 | 106,442 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $2,680,424 | 90,159 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $6,032,493 | 278,380 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $5,712,322 | 256,158 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $707,865 | 46,509 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||